Dual-target hUCMSCs/EVs therapy for autism spectrum disorder: remodeling gut microbiota and modulating neuroimmune crosstalk in a valproic acid-induced C57BL/6 mice model
Caixia Wu, Xianjie Li, Xiaoya Yang, Han Wang, Guanzhen Lin, Zhaoming Liu · 2025
Read Dual-target hUCMSCs/EVs therapy for autism spectrum disorder: remodeling gut microbiota and modulating neuroimmune crosstalk in a valproic acid-induced C57BL/6 mice model by Caixia Wu, Xianjie Li, Xiaoya Yang, Han Wang, Guanzhen Lin, Zhaoming Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12817768.txt.
Description
Caixia Wu and co-authors test stem cells plus their released vesicles as a combined therapy for autism in mice, in work published in 2025. Autism involves social communication deficits and repetitive behaviour. Evidence links it to immune imbalance in the brain and disturbed gut microbes, yet few therapies target those routes.
The team used mice exposed before birth to a drug that induces autism-like traits. Groups received stem cells from human umbilical cords, their vesicles, both, or neither. Each single treatment helped some symptoms but left gaps. The combination gave the strongest gains in social behaviour and cut repetitive acts. It also calmed brain inflammation, repaired cell structures, and restored gut microbe balance. The authors present the dual approach as a candidate for further study.
Catalog record
| CREATOR | Caixia Wu, Xianjie Li, Xiaoya Yang, Han Wang, Guanzhen Lin, Zhaoming Liu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |